Peptides omenala maka nyocha ndị njem SLC

Kedu ihe bụ ndị na-ebugharị SLC na gịnị kpatara ha ji bụrụ ebumnuche siri ike?

Ndị na-ebu SLC bụ protein na-ebu solute nke na-ebugharị ions, nri, neurotransmitters na ọgwụ n'ofe cell membranes, na ụmụ mmadụ nwere 464 mara òtù gbasaa gafee 70 ezinụlọ (Akụkọ-ọgwụ, 2026-09-10). Ha bụkwa ihe ọmụmụ ụlọ nyocha siri ike, na ihe kpatara ya bụ nhazi karịa usoro.

Ihe isi ike na-amalite na ije. Ndị na-ebu SLC bụ protein akpụkpọ anụ arụnyere site na ọtụtụ helices transmembrane, nke na-eme ka ha sie ike ikwupụta, solubilise, sachaa na crystallize (PMC, 2025-09-02). Ọtụtụ na-arụ ọrụ site na usoro nnweta ọzọ, na-agbanwe n'etiti ihu n'ime, steeti kpọchiri akpọchi na ihu apụta, yabụ otu nnwale na-achọ ijide otu ngbanwe karịa foto niile. Ọkwa okwu obodo na-adịkarị ala, nke na-eme ka ọ dị ọcha, antibody ọgbọ na structural ọrụ, na ibugharị protein ahụ n'ime ihe ngwọta nke ncha nwere ike ịgbagọ ma ọ bụ mebie usoro ị na-achọ ịmụ.

Ngụgharị na-arụ ọrụ ka amachibidoro ya. Ọtụtụ SLC enweghị mkpụrụ ama ama ma ọ bụ nyocha nke abụọ siri ike, na nha njem na-enwe mgbagwoju anya site na nkọwapụta mkpụrụ, electroneutrality, localization, directionality na artefacts, na mkpirisi mkpụrụ okwu ịkwa iko na-agbakwunye nkọwa nkọwa ọzọ.

Ihe si na ya pụta bụ ezinụlọ nke ọgwụ emetụbeghị aka. Ọgwụ ndị dị adị na-agwa naanị obere akụkụ nke ezinụlọ SLC (Akụkọ-ọgwụ, 2026-09-10), na otu 2026 mpempe echiche na-eme atụmatụ na ezinụlọ karịrị akarị 400 ndị otu, ihe dị ka otu ụzọ n'ụzọ atọ enwebeghị ligand amata ma ọlị (Ọnwụnwa Clinical Vanguard, 2026-09-07). Ngwakọta ahụ, siri ike ikwupụta, siri ike ijide n'otu steeti, siri ike tụọ, bụ kpọmkwem ihe kpatara peptide reagent mara mma ji enweta ọnọdụ ya n'ọrụ mbufe mbụ..

Ihe kpatara Peptides omenala maka nyocha ndị njem SLC dabara na nchọpụta mmalite

peptides omenala maka nyocha ndị na-ebu SLC dabara na nchọta mbụ n'ihi na akọwara ha usoro, reagents labelable na modifiable nke enwere ike wuo megide ebumnuche ebe mgbochi nje, ogige ngwá ọrụ na usoro ihe ọmụmụ ihe akwụsịla. Oghere ngwa-ngwakọta bụ ihe akaebe doro anya maka dabara ahụ. A 2024 nnyocha e mere nke SLC ngwá ọrụ ogige na Frontiers na Pharmacology kpuchie 20,678 obere ụmụ irighiri ihe pụrụ iche gafee 199 SLC na, mgbe itinye ngwa-ngwakọta njirisi, rutere na 6,876 ndị inhibitors na-ekpuchi naanị 51 ndị njem. Otu nnyocha ahụ chọpụtara na 530 nke 810 Ngwakọta/SLC ụzọ abụọ ejiri aka chịkọta anọghị na ọdụ data anwalela, na maka ọtụtụ SLC ndị metụtara ọrịa, nyocha dị ebe ọ nweghị ngwa ọrụ achọpụtala ma ọlị.

Ntugharị igodo: Levers anọ na-ekpebi ma peptide reagent na-arụ ọrụ n'ọrụ njem: usoro ị na-ahọrọ, akara ị na-etinye, nkwụsi ike mgbanwe ị na-etinye, na ihe akaebe nyocha ị nwere ike igosi maka nza.

The Validation Cascade: Nkwenye ebumnuche, Njide, Onyonyo, Mmepe nyocha

Gbaa ngwa anọ ahụ n'usoro. Usoro ọ bụla nke reagent na ihe akaebe chọrọ na-egbochi ọzọ, yabụ ịga n'ihu na-apụtakarị ịzụta otu peptide ugboro abụọ.

The cascade abụghị usoro iwu. Ndị mbụ ezubere iche maka SLC na-eji nkwalite, nkwụsi ike na usoro ọgwụgwọ mkpụrụ ndụ ihe nketa adịlarị na mmepe ụlọọgwụ maka Akwụkwụ na-adọ, Autism ụdịdị dị iche iche ọrịa na mgbu na-adịghị ala ala, ya na nnwale-ọgwụgwọ mkpụrụ ndụ na-enyocha nsogbu neurodevelopmental metụtara SLC6A1, Ọrịa deficiency glut1 na ọrịa metụtara SLC13A5 (Nyochaa ebumnuche ọgwụ ọjọọ, 2026-09-11).

Mmepe nke nyocha na-anọdụ ala maka ihe kpatara ya: Odida obodo na-arụ ọrụ maka ndị na-ebugharị ndị a dị warara, ya mere ọgụgụ ị nwere ike wulite dabere n'ihe usoro ndị mbụ gosipụtara.

Ịmepụta usoro omenala maka ebumnuche ndị njem

Nhazi usoro na-amalite site na mpaghara ịchọrọ ịjụ ajụjụ, ọ bụghị site na katalọgụ. Buru ụzọ kpebie ma peptide ga-eṅomi ligand ebufe eke, asọmpi n'ebe a na-ekekọta ama ama, ma ọ bụ Ụlọ ahịa naanị bulie ihe mgbochi megide akaghị. Mkpebi ahụ na-edozi ogologo oge, kemịkalụ ọnụ, na ole nke usoro nwere ike ịgbanwe na-enweghị na-efunahụ mmekọrịta ị chọrọ tụọ.

Ndị na-ebu SLC enweghị mgbaghara na-enweghị atụ ebe a. Mgbatị transmembrane ha bụ hydrophobic na ọdụ cytoplasmic ha na-abụkarị ọgaranya, na njirimara abụọ ahụ na-eme ka mgbakọ usoro siri ike na ntughari nchacha dị ọcha siri ike karịa ihe e ji emepụta protein soluble-protein.. Na-atụ anya mkpụrụ crud dị ala, nchịkọta ọzọ n'oge cleavage, na windo nchacha dị warara karị. PHT1 (SLC15A4) mbanye nke TASL bụ ebe ntụaka bara uru: ọ na-egosi njirimara SLC-ligand kpebiri na ọkwa molekul, nke bụ ọkwa nke nkọwa usoro gị kwesịrị ịkwanyere ùgwù (Nkwukọrịta okike, 2023).

Iwu abụọ bara uru na-esochi. Nye iwu ihe ntụnye aka na-enweghị akara n'akụkụ ụdị ọ bụla akpọrọ, ya mere enwere ike tụọ onyinye akara akara kama iche. Na na-emeso usoro nhọrọ dị ka uko ụlọ na mgbe e mesịrị arụmọrụ: Enweghị ọkwa nchacha ọcha ma ọ bụ njikarịcha nyocha na-enwetaghachi mmekọrịta nke usoro ahụ emebeghị.

Akara Fluorescent na Biotin: Ịhọrọ nyocha ziri ezi

Pick the label from the assay format, not from what ships fastest. Fluorescent labels suit imaging and subcellular localisation; biotin labels suit binding, pull-down and surface-capture formats. Get that order backwards and the reagent can invalidate the readout.

The caveat is worth stating plainly: the fluorophore itself can alter transport behaviour, so a labelled peptide is not automatically a faithful surrogate for the unlabelled one (PMC, imaging therapeutic peptide transport across intestinal barriers, 2021-06-15). Treat any shift in apparent affinity or uptake rate as a property of the conjugate until you have shown otherwise.

Biotin’s advantage is that it stays out of the optical path. Usoro nnabata cytometry nke otu mkpụrụ ndụ ebipụtara na-akọwapụta fluorescence peptide n'otu sel ma na-eji sodium azide kewapụ ntinye nke dabere na ume na njide elu., wee trypan acha anụnụ anụnụ, trypsin ma ọ bụ pronase ịdọpụpụ ikewapụ internalized na peptide nke nwere elu (PMC, otu-cell eruba cytometry peptide nnabata, 2016-12-05). Njikwa ndị ahụ bụ ihe na-atụgharị nọmba fluorescence ka ọ bụrụ nkwupụta ọrụ, na ha na-arụ ọrụ naanị ma ọ bụrụ na ị maara akụkụ nke akpụkpọ ahụ mgbama gị na-anọdụ ala.

Wepụta ego akara n'ime usoro iheomume yana nhazi. N-terminal biotin, biotin-Ahx, Mgbakwunye FAM na FITC-Ahx na-ebu ntaramahụhụ ụbọchị abụọ nke azụmahịa n'elu nhazi ọkọlọtọ. (Ọrụ peptide omenala GenScript, ibe ọrụ ndụ, ewepụtara 2026-02-12).

Ntugharị igodo： Match the label to the assay format first, then confirm the conjugate behaves like the parent peptide before you build a conclusion on it.

Mgbanwe na-eme ka nkwụsi ike na nkwụsị ahịa ha

Stability-enhancing peptide modifications extend how long a construct survives an assay, but the same chemistry that buys that window can shift how tightly the peptide binds its transporter. Treat every modification as a variable that needs its own control, not as a free upgrade.

The routine terminal protections cost nothing extra. N-terminal acetylation and C-terminal amidation are standard options, na ndị na-ebubata ya na-enyekarị ha n'enweghị ụgwọ ọzọ yana katalọgụ karịrị 300 mgbanwe otu ọrụ (GenScript). Mgbochi ọnụ na-ebute ụzọ megide mbelata exopeptidase, nke na-abụkarị ihe mbụ na-emebi peptide na serum ma ọ bụ ogologo oge.

Uru ọ bụla na-ebu ọnụ. Ogo ịdị ọcha dị elu na-enweta obere ihe: nyocha ọkwa na 85-95% ịdị ọcha na-alaghachi 40-60% nke crude, na ultra-dị ọcha ihe na 98% ma ọ bụ n'elu na-alaghachi naanị 20-40% (KeriSite International, ewepụtara 2026-07-09). Chemistry Counterion bụ mmachi metụtara ya: trifluoroacetate na-ejikọta ya na N-terminus n'efu yana ihe fọdụrụnụ dị ka Arg., Lys, na Ya, na iwepụ ya maka ụdị nnu na-ejikọta ya na-ewe ihe mgbakwunye ion-exchange (Bachem, ewepụtara 2026-07-28).

Ịdọ aka ná ntị: Nrụpụta kwụsiri ike nwere ike gbanwee mmekọrịta nke onye na-ebugharị ma ọ bụ mechie windo nyocha nke ị malitere ịtụ.. Gbaa comparator na-agbanweghị agbanwe n'otu nnwale ahụ ka enwere ike ime mgbanwe ọ bụla na mgbanwe ahụ karịa na peptide n'onwe ya..

Nnwale nyocha na QC: Ihe ngwugwu data gị ga-egosi

Pasent dị ọcha n'onwe ya egosighi ihe ọ bụla. Ọnụọgụ ahụ na-aghọ naanị ihe akaebe mgbe ọ bịarutere na usoro mepụtara ya, nlele njirimara nke na-akwado usoro, na njirisi nnabata nke onye na-ebubata ya na-etinye n'ihu tupu ọsọ ahụ. Rịọ ha atọ, ma rịọ maka data raw n'azụ ha.

Ọnụ ọgụgụ dị ọcha ịchọrọ dabere na ihe peptide ga-eme. Ntuziaka Bachem maka njikwa mma peptide na-edobe ọnụ ụzọ karịa 95% maka ọmụmụ mmekọrịta receptor-ligand na igbochi ma ọ bụ nyocha asọmpi, 90 ka 95% maka ọrụ substrate nke enzyme quantitative, na n'elu 80% maka Western blotting. Onye na-ebubata ihe na-ehota otu ọkwa maka ngwa ọ bụla na-agwa gị na ha echeghị maka nke gị.

Identity bụ ule dị iche na ịdị ọcha. A peptide nwere ike ịbụ 98% dị ọcha ma ka bụrụ usoro na-ezighi ezi. Ntuziaka QC nke Wikipept na-anabata uka tụrụ atụ n'ime ±2 Da nke usoro ihe ọmụmụ monoisotopic, na-agbasawanye ruo ±5 Da n'elu 3 kDa, mgbe Ụlọ ọrụ ILS na-akọ windo ndị siri ike site na LC-MS: ± 0.5 Da na otu quadrupole na ± 0.01 Da na ngwá ọrụ dị elu.. Dakọtara na nnabata na ngwa, ma lelee na oke a kọrọ bụ nke a hụrụ, ọbụghị uru usoro iwu ekwughachiri.

Mgbe ahụ enwere ọdịiche dị n'etiti ịdị ọcha na ọnụọgụ. Mpempe akwụkwọ akpọrọ 10 mg nwere ike ijide naanị 6 ka 8 mg nke peptide n'ezie ozugbo a na-agụta ihe mgbochi na mmiri, dị ka ILS Labs si edetu na otu nyocha QC. Ya mere ọdịnaya peptide net net dị na asambodo n'akụkụ ịdị ọcha, na ihe kpatara na usoro bara ụba nke isi na-egosipụtakarị ọdịnaya net dị ala site na nhazi nnu, isi ihe Bachem kwuru hoo haa. Tụlee itinye uche gị na-arụ ọrụ megide ọdịnaya netwọkụ, ọ bụghị vial arọ, ma ọ bụ molarity ọ bụla dị n'okpuru ala na-ezighi ezi.

Endotoxin chọrọ ọnụ ọgụgụ na ọmụmụ ihe. A na-akọwakarị ihe ọkwa nyocha n'okpuru 10 EU/mg, preclinical n'okpuru 1 EU/mg, na Clinical n'okpuru 0.25 EU/mg n'okpuru oke nne na nna FDA, na ule LAL kwa USP <85> dị ka usoro ndekọ (wikipept; Ụlọ ọrụ ILS). Maka nyocha ihe na-ebugharị cell, ọkwa ọkwa nyocha na-ezukarị oke, ma ekwesịrị ikwupụta nkọwapụta kama iche.

Ngwugwu ojiji nyocha zuru oke na-ebu ịdị ọcha RP-HPLC na UV 214 ma ọ bụ 220 nm na kọlụm C18 nwere acetonitrile/0.1% TFA gradient, LC-MS njirimara, net peptide ọdịnaya, LAL endotoxin kwa USP <85>, ihuenyo amụ nwa ngwa ngwa, na ọla dị arọ site na ICP-MS kwa USP <233> na m Q3D (Ụlọ ọrụ ILS). Ihe adịghị ọcha n'elu 0.5% ekwesịrị ka e ji mara karịa naanị ịgụ ya, ya na LC-MS/MS ejiri maka mkpuchi usoro yana njirimara nkeji (wikipept).

Nnwale bara uru nke ngwugwu data dị mfe: onye nleba anya nwere ike megharịa nsonaazụ gị na ya na-akpọtụrụ onye na-ebubata ya? Ọ bụrụ na chromatogram enweghị windo ntinye, uka ụdịdị dị iche iche enweghị uru hụrụ, ma ọ bụ ọdịnaya net na-efu, azịza ya bụ mba.

Nkwekọrịta Lot-to-Lot yana ịgụ akwụkwọ nyocha

Asambodo nyocha bụ nkwupụta nke ndị na-ebubata ihe gbasara otu ogbe, ọ bụghị nkwa na ogbe na-esote ga-adaba na ya. Were ya dị ka mmalite maka nkwenye, ma kọwapụta nnabata ị ga-anabata tupu itinye iwu ahụ.

Ọdịiche dị n'etiti ọnụ ọgụgụ ịdị ọcha ekwuputara na nke a tụrụ nwere ike ịdị obosara. A 2022 inter-laboratory ọmụmụ chọpụtara na peptides akara na 98% ma ọ bụ karịa site na otu usoro HPLC sitere na 94.2% ka 99.1% mgbe ụlọ nyocha atọ megharịrị ha na kọlụm dị iche iche na usoro mkpanaka (KeriSite International, ewepụtara 2026-07-09). Nhọrọ usoro naanị na-akpali ọnụọgụgụ.

Okwu nyochagharị ndị nọọrọ onwe ha na-atụ aka n'otu ụzọ ahụ. Na otu set nke ise ngwaahịa re-anwale site na ibu otu nke 30, anọ tụrụ karịa 10% n'okpuru ịdị ọcha CoA ha, na ngwaahịa edepụtara n'elu 98% laghachiri na 67%. Ihe atụ dị iche gosiri a 99.2% CoA nke ọdịnaya peptide bu n'uche bụ 76% n'ihi na ihe jikọrọ ọnụ 16-mer variant welitere ọgụgụ ịdị ọcha (KeriSite International, ewepụtara 2026-07-09). Rịba ama isi iyi: KeriSite bụ onye na-eweta asọmpi, na ikpe ndị a bụ onye na-ere ahịa dere, ya mere gụọ ha dị ka ihe atụ nke ọdịda mode kama a na-anọpụ iche nnyocha e mere.

Ihe akụkọ CoA dị iche site n'aka onye na-ere ahịa. Nnukwu ụlọ ọrụ QC na-ebubata gụnyere ọdịnaya mmiri nke Karl Fischer titration, ọdịnaya nitrogen site na nyocha elementrị dị ka ọnụọgụ ọdịnaya peptide, ihe fọdụrụ TFA site na ion chromatography, na ngalaba-elution megide ọkọlọtọ ntụaka (Bachem, ewepụtara 2026-07-28). Ọ bụrụ na CoA gị depụtara ịdị ọcha na ịdị arọ naanị, ị na-efunahụ ubi ndị na-akọwa mgbanwe n'etiti ọmụmụ ihe.

Tinye ebumnuche nnabata n'usoro n'onwe ya. Ndị a bụ nnabata nke batch-to-batch kwesịrị ịkọwapụta:

Ndị na-ebubata ihe na-arụ ọrụ iji mesie ebumnuche ime ụlọ na-akọ CV dị ọcha n'okpuru 0.5% na oge njigide CV n'okpuru 1.0%, na n'ime-ụlọ nkọwapụta ọnụego ngafe n'elu 95% (KeriSite International, ewepụtara 2026-07-09). Rịọ onye na-ebubata ngwaahịa maka data CV nke ọtụtụ batch ha, ọ bụghị naanị otu ogbe CoA. Ịnọgidesi ike n'ọtụtụ-na-nza bụ nkwupụta usoro, na naanị ihe akaebe maka ya bụ nkesa gafee batches.

Echiche ụgha ndị a na-enwekarị gbasara Peptide Reagents na Ọrụ Ụgbọ njem

Echiche ezighi ezi kachasị ọnụ na ọrụ ụgbọ njem bụ na ọnụ ọgụgụ ịdị ọcha dị elu pụtara reagent dị mma. Ịdị ọcha bụ otu ihe n'etiti ọtụtụ, na echiche ndị na-eji nwayọọ mebie peptide na-anọkarị n'èzí ọnụ ọgụgụ dị ọcha kpamkpam.

Ihe peptide akpọrọ aha na-agbanwe agbanwe yana analọgụ enweghị akara ya. Ọ bụghị. Ịtinye fluorophore ma ọ bụ biotin na-agbanwe ịdị arọ molekụla, hydrophobicity, na mgbe transporter affinity, yabụ nyocha akpọrọ chọrọ njirimara njide nke ya kama iketa ọnụọgụ peptide enweghị akara.. Mmepụta Peptide

Ọnụ ọgụgụ ịdị ọcha nke asambodo-nke nyocha na-enyefe gafee usoro nyocha. Ọ naghị eme ya. Uru enwetara site na otu usoro HPLC enweghị atụ na uru sitere na gradient dị iche, kọlụm, ma ọ bụ ogologo oge nchọpụta, ya mere tulee ọnụ ọgụgụ naanị mgbe usoro ahụ dabara.

A na-eleghara ọdịnaya peptide net anya mgbe ị na-agbakọ molarity. Ọdịnaya peptide net na-agbanwe mkpokọta molarity ọ bụla. Ịtụle ihe site na nnukwu oke na ile ya anya dị ka peptide dị ọcha na-ekwupụta ọnụọgụ reagent na-arụ ọrụ na tube., mgbe ụfọdụ site na oke oke.

Nnụnụ TFA-nnu na-aga ozugbo n'ime nyocha cell na-enwe mmetụta mgbochi. A na-emetụta nyocha ndị dabere na cell site na mgbochi, na ọkwa e depụtara maka nyocha ndị ahụ bụ ≥98% peptide ọdịnaya ewepụtara dị ka TFA ma ọ bụ acetate nnu. (KeriSite International, 2026-07-09). Ebe mgbochi n'onwe ya na-akpaghasị ịgụ ihe, kwado ụdị nnu tupu nyocha ahụ, ọ bụghị mgbe emechara.

Ntugharị igodo: Njehie kachasị ọnụ abụghị ọnụ ọgụgụ ịdị ọcha dị ala. Ọ bụ reagent gafere nkọwapụta nke ọ bụla mgbe ọ na-adaba n'echiche a na-enyo enyo gbasara ịkpọ aha, usoro, molarity, ma ọ bụ ụdị nnu.

Ihe Nlereanya rụrụ arụ: Otu ewu Site na Cascade

Otu ndị na-ebu njem na-amalite site na ebumnuche mkpụrụ osisi amaara na-echepụta peptides atọ n'otu n'otu: Analọgụ ntụaka enweghị akara, nyocha nke akpọrọ fluorescent, yana reagent njide biotinylated. Analọọgụ ntụaka na-esetịpụ ntọala. Enweghị ya, enweghị ike ịsị ngbanwe nke mgbama sitere na nyocha nke akara akara na akara kama ịbụ usoro n'onwe ya..

Nhazi usoro na-amalite site na njirimara njirimara amaara na ọ ga-eji, ebe ọ bụ na otu esi edozi peptide site na SLC na-adabere n'ichekwa kọntaktị ndị ahụ. Ụdị nke akpọnyere aha na biotinylated wee buru otu isi usoro, na mgbanwe etinyere na njedebe ma ọ bụ ihe mgbaze na-ekpughere karịa n'ime ihu njide.

Na nyocha nke nyocha, njikwa azide na iwepụ ihe na-eme ka mgbama ahụ na-egosipụta njikọ dị iche iche kama ịgbasa ngwa ngwa.. QC na-emechi ihe owuwu ahụ tupu ya eruo nzọụkwụ ahụ: matriks nke ịdị ọcha site na ngwa na-akwado na peptide na-arụ ọrụ na ebe nchekwa na ọnọdụ nchọpụta echere, na ọdịnaya peptide net, ọ bụghị oke ibu, na-esetịpụ molarity eji na mgbako njide.

Oke na mgbe Peptides bụ Ngwá Ọrụ Na-ezighi ezi

Peptides bụ ngwá ọrụ na-ezighi ezi mgbe mmemme chọrọ akwụkwọ ọgụgụ njem na-arụ ọrụ nke na-adịbeghị. Ogige ihe na-ebufe nwere odida ala na-arụ ọrụ dị warara, Ya mere, peptide reagent nwere ike inye njikọ, localization ma ọ bụ data mmekọrịta, mana ọ nweghị ike iguzo maka nha njem n'onwe ya. Ọ bụrụ na ajụjụ bụ ma mkpụrụ osisi na-agafe n'ime akpụkpọ ahụ, ihe nyocha peptide zara ajụjụ dị iche.

Usoro ọzọ-nweta na-eweta oke nke abụọ. N'ihi na protein ndị a na-agbakọ n'etiti ime- na ngbanwe chere ihu, nnwale na-ejidekarị otu steeti n'otu oge, na peptide kachasị mma megide otu steeti nwere ike ọ gaghị akọ na nke ọzọ. Mkpọsa aha na-agbakọta nke a: itinye fluorophore ma ọ bụ biotin nwere ike imebi nha njide kpamkpam, na mgbanwe na-akwalite nkwụsi ike nwere ike ịgbanwe mmekọrịta zuru oke nke na ihe nrụpụta kwụsiri ike agaghịkwa abụ onye ntụnyere kpọmkwem megide usoro nne na nna..

Were nke ọ bụla n'ime ihe ndị a dị ka ihe mere ị ga-eji ruo maka usoro ihe ọmụmụ ihe nhazi, Ngwa ngwa akụrụngwa kwadoro ma ọ bụ nyocha orthogonal kama. Ikwubigara ihe klaasị reagent nwere ike gosi na-efu otu nkeji nkeji mmemme.

Na-amalite: Nzọụkwụ mbụ maka ọrụ ụgbọ njem Peptide

Kọwaa ihe nnwale nke reagent ga-eje ozi tupu ị rịọ ihe ọ bụla. Usoro nnabata na-ebute ụzọ: ọkwa ịdị ọcha, net peptide ọdịnaya, ụdị nnu, nnabata ogbe-na-ogbe, na ụzọ nyocha nke ga-egosipụta nke ọ bụla. Ntụtu a rịọrọ tupu nkọwapụta ndị ahụ adị na-abịakarị n'echiche nke ị họrọghị.

Nzọụkwụ atọ na-ewepụ ọtụtụ esemokwu ahụ:

1. Dee njirisi nnabata, wee rịọ maka ntinye akwụkwọ. Kwupụta usoro nyocha, ihe nchekwa, itinye uche na-arụ ọrụ, na ndidi nke ị ga-anabata n'etiti nza.

2. Nye iwu ihe ntụnye aka na-enweghị akara n'akụkụ ihe owuwu ahụ akpọpụtara. Ọ na-enye gị njikwa maka akara n'onwe ya yana ụzọ iji gosi na mgbanwe mgbaàmà ọ bụla sitere na mgbanwe ahụ, ọ bụghị peptide.

3. Rịọ ngwugwu nyocha zuru ezu, ọ bụghị ọnụ ọgụgụ dị ọcha. HPLC, uka spectrometry, na akwụkwọ nyocha ka ị nyochaa njirimara yana ịdị ọcha.

Hazie usoro iheomume gburugburu kemistri. Ọkọlọtọ omenala njikọ na-agba banyere 2 ka 3 izu, gbanwetụrụ usoro 4 ka 6 izu, na conjugation 3 ka 5 izu (Tsingke peptide njikọ ọrụ, ewepụtara 2026-08-21). Ọ bụrụ na edobere ụbọchị nyocha gị, malite na arụrụ arụrụ arụ.

Ọ bụrụ na ịchọrọ echiche nke abụọ maka ma ebumnuche gị na agụpụta gị dabara tupu ịme usoro, gwa onye ọkachamara okwu ma ọ bụ rịọ maka ntule ike. MOL Mgbanwe na-enye ọrụ peptide omenala, ya mere were nke a dị ka mmasị azụmahịa mgbe ị na-atụle ndụmọdụ dị n'elu.

Ajụjụ a na-ajụkarị

Kedu ọkwa ịdị ọcha ka m chọrọ maka nyocha njide nke njem?

N'elu 95% bụ ọnụ ụzọ na-arụ ọrụ maka mmekọrịta receptor-ligand na igbochi ma ọ bụ nyocha asọmpi, kwa ntụzịaka peptide ọcha nke Bachem. Naanị ịdị ọcha anaghị eme reagent dabara maka ojiji: jikọta ya na nkwenye njirimara yana ọnụ ọgụgụ ọdịnaya peptide net tupu ị gbakọọ molarity.

Ihe akara fluorescent nwere ike gbanwee ka peptide m si emekọrịta ihe na onye njem?

Ee. Fluorophore n'onwe ya nwere ike gbanwee omume njem, dị ka a kọrọ na a 2021 ọmụmụ nke fluorescent substrate analogues. Gbaa ihe nleba anya na-enweghị akara n'otu nyocha ka ị nwee ike ikewapụta mmetụta akara na mmetụta usoro.

Kedu ka m ga-esi chọpụta njirimara peptide na ọ bụghị naanị ịdị ọcha ya?

Nyochaa site na uka. Uka a tụrụ atụ kwesịrị ịdaba n'ime ± 2 Da nke theoretical monoisotopic mass site na ESI-MS ma ọ bụ MALDI-TOF, na-agbatị ± 0.5 Da site na otu-quad LC-MS na ± 0.01 Da site na nnukwu mkpebi MS, dị ka nkọwa nyocha nke ILS Laboratories si dị. Nchọta ịdị ọcha na-enweghị oke ụdịdị dị iche iche agwaghị gị ihe ọ bụla gbasara ma emere usoro ziri ezi.

Kedu ihe ọdịnaya peptide net pụtara na gịnị kpatara o ji dị mkpa?

Ọdịnaya peptide net bụ oke nke peptide n'ezie na vial ozugbo a gbakọrọ ọnụ na mmiri fọdụrụnụ., na ọ nwere ike ịnọdụ ala nke ọma n'okpuru ọnụ ọgụgụ dị ọcha. ILS Laboratories kwuru na 10 mg nke ntụ ntụ lyophilized nwere ike ịnwe naanị 6 ka 8 mg nke peptide, nke na-agbanwe mgbako molarity ọ bụla downstream.

M ga-arịọ TFA ma ọ bụ acetate nnu ụdị?

Ọ dabere na nyocha. Trifluoroacetate na-ejikọta ya na N-terminus n'efu na agbụ akụkụ akụkụ na enweghị ike iwepụ ya kpamkpam., ya mere, ọrụ dabere cell na-eche nche na-achọ ka nnu na-agbanwe agbanwe ion, ka Bachem na KeriSite na-akọwa. Nnwale njide na nchekwa na-anabatakarị TFA; Nlebanya ụgbọ njem dị ndụ anaghị adịkarị.

Ego ole ka m ga-atụ anya mgbanwe nza na nza n'etiti batches peptide?

Karịa ọtụtụ ndị nchọpụta na-eche. Akara Peptides na 98% ma ọ bụ karịa site na otu usoro HPLC sitere na 94.2% ka 99.1% gafee ụlọ nyocha atọ na a 2022 ntụnyere n'etiti ụlọ nyocha e bipụtara na Amino Acids. Ezipụta nnabata nke ogbe-na-ogbe n'usoro: oge njigide n'ime ± 0.2 min, ịdị ọcha n'ime ± 0.5% mpaghara, peptide ọdịnaya n'ime ± 5%.

Ebee ka mmemme transporter SLC na-aga na-esote?

N'ebe usoro nyocha nke na-agụ ọrụ ndị na-ebugharị na sistemu ndụ karịa na nkwadebe akpụkpọ anụ dịpụrụ adịpụ, nke na-ebuli ogwe aka maka imepụta nyocha. A na-akọwawanye peptides nke a na-akpọ fluorescent maka imaging na-ebufe na peptides biotinylated maka ọmụmụ ihe na-ekekọta njem na-akọwawanye ọnụ n'otu ọrụ ahụ ka otu usoro wee na-eje ozi abụọ ahụ..

Mmechi

The reagent dị mma naanị dị ka ihe nyocha n'azụ ya, na usoro cascade na-ekpebi ihe akaebe ịchọrọ mbụ. Peptide omenala maka nyocha ndị na-ebugharị SLC na-enweta ọnọdụ ya n'ọrụ mgbe usoro ahụ dabara na ebumnuche, akara ahụ anaghị agbagọ bayoloji ị na-atụ, Mgbanwe nkwụsi ike ọ bụla ziri ezi megide azụmaahịa ya, na ngwugwu data na-egosi njirimara, ịdị ọcha, na net ọdịnaya kama ikwupụta ha. Nweta usoro ahụ ezighi ezi ma kwụọ ụgwọ ya ma emechaa, nke bụ kpọmkwem ebe mgbanwe nza-na-nza nke a na-ahụ na nyochagharị onwe ya na-aghọ ọnụ.

Ogige ahụ eguzoghị otu ebe. Mmemme SLC na-apụta ugbu a na mmepe ụlọ ọgwụ na-agbali maka usoro ịgbalite yana usoro ọgwụgwọ mkpụrụ ndụ ihe nketa, yabụ ihe ndị chọrọ reagent ị na-ede n'ime nkọwapụta taa ga-aga n'ihu na-agbanwe. Wulite àgwà ugbu a: kọwapụta nyocha mbụ, wee nyocha, mgbe ahụ, njirisi nnabata nke nyocha. Nzọụkwụ mbụ na mmalite bụ nke ị ga-alaghachi na otu gị n'izu a.